Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Xiaojia Wang PhD"'
Publikováno v:
Cancer Control, Vol 31 (2024)
Breast cancer has the highest incidence among female malignancies, significantly impacting women’s health. Recently, numerous HER2-targeted therapies have achieved excellent clinical outcomes. Currently, anti-HER2 drugs are divided into three main
Externí odkaz:
https://doaj.org/article/0fd413af1986456d84bd137043986e3a
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Breast cancer is the most common malignancy in women, and some subtypes are associated with a poor prognosis with a lack of efficacious therapy. Moreover, immunotherapy and the use of other novel antibody‒drug conjugates have been rapidly incorpora
Externí odkaz:
https://doaj.org/article/853c0784d46343fc875b3a93cd83c712
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Recent studies have demonstrated that the combination of Cyclin-Dependent Kinase 4/6 Inhibitor (CDK4/6i) and endocrine therapy (ET) is more effective than ET alone and significantly improves progression-free survival (PFS) and overall survival (OS) i
Externí odkaz:
https://doaj.org/article/2c1b4db33d4f456687a10115ba65d1eb